Category: Pharmaceuticals
Pharmaceuticals market research reports by GlobalData
-
Galderma SA (GALD) - Financial and Strategic SWOT Analysis Review
Galderma SA (GALD) - Financial and Strategic SWOT Analysis Review - provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and ... Read More
-
Shionogi & Co Ltd (4507) - Financial and Strategic SWOT Analysis Review
Shionogi & Co Ltd (4507) - Financial and Strategic SWOT Analysis Review - provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesse ... Read More
-
Checkpoint Therapeutics Inc (CKPT) - Financial and Strategic SWOT Analysis Review
Checkpoint Therapeutics Inc (CKPT) - Financial and Strategic SWOT Analysis Review - provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and ... Read More
-
Skinvisible Inc (SKVI) - Financial and Strategic SWOT Analysis Review
Skinvisible Inc (SKVI) - Financial and Strategic SWOT Analysis Review - provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses ... Read More
-
Phoenix Pharmahandel GmbH & Co KG - Strategic SWOT Analysis Review
Phoenix Pharmahandel GmbH & Co KG - Strategic SWOT Analysis Review - provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major ... Read More
-
Eli Lilly and Co (LLY) - Financial and Strategic SWOT Analysis Review
Eli Lilly and Co (LLY) - Financial and Strategic SWOT Analysis Review - provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses ... Read More
-
Navamedic ASA (NAVA) - Financial and Strategic SWOT Analysis Review
Navamedic ASA (NAVA) - Financial and Strategic SWOT Analysis Review - provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses an ... Read More
-
Santen Pharmaceutical Co Ltd (4536) - Financial and Strategic SWOT Analysis Review
Santen Pharmaceutical Co Ltd (4536) - Financial and Strategic SWOT Analysis Review - provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths an ... Read More
-
Esophageal Cancer: Competitive Landscape
Esophageal Cancer: Competitive Landscape Summary This reports provides a data-driven overview of the current and future competitive landscape in Esophageal Cancer therapeutics. In 2024, more than 410,000 diagnosed incident cases of EC are anticipated in the 16 countries covered in GlobalData’s epide ... Read More
-
Sepsis: Epidemiology Forecast to 2033
Sepsis: Epidemiology Forecast to 2033 Summary Sepsis is a life-threatening complication arising from an infection, which occurs when the body’s response to the infection damages its own tissues and organs. Sepsis causes multiple organ failure and death, especially if it is not recognized early and t ... Read More
-
Limb-Girdle Muscular Dystrophy (LGMD): Competitive Landscape
Limb-Girdle Muscular Dystrophy (LGMD): Competitive Landscape Summary This reports provides a data-driven overview of the current and future competitive landscape in Limb-Girdle Muscular Dystrophy therapeutics. In 2024, more than 111,000 diagnosed prevalent cases of LGMD are anticipated in the 16 cou ... Read More
-
Gonorrhea (GN): Competitive Landscape
Gonorrhea (GN): Competitive Landscape Summary This reports provides a data-driven overview of the current and future competitive landscape in Gonorrhea therapeutics. In 2024, more than 3.7 million diagnosed incident cases of GN are anticipated in the 16 countries covered in GlobalData’s epidemiology ... Read More
-
Multiple System Atrophy (MSA): Competitive Landscape
Multiple System Atrophy (MSA): Competitive Landscape Summary This reports provides a data-driven overview of the current and future competitive landscape in Multiple System Atrophy therapeutics. In 2024, more than 226,000 diagnosed prevalent cases of MSA are anticipated in the 16 countries covered i ... Read More
-
Glycogen Storage Disorders (GSD): Competitive Landscape
Glycogen Storage Disorders (GSD): Competitive Landscape Summary This reports provides a data-driven overview of the current and future competitive landscape in Glycogen Storage Disorders therapeutics. In 2024, more than 2,000 diagnosed incident cases of GSD are anticipated in the 16 countries covere ... Read More
-
Newron Pharmaceuticals SpA (NWRN) - Financial and Strategic SWOT Analysis Review
Newron Pharmaceuticals SpA (NWRN) - Financial and Strategic SWOT Analysis Review Newron Pharmaceuticals SpA (NWRN) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData t ... Read More
-
CASI Pharmaceuticals Inc (CASI) - Financial and Strategic SWOT Analysis Review
CASI Pharmaceuticals Inc (CASI) - Financial and Strategic SWOT Analysis Review CASI Pharmaceuticals Inc (CASI) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to br ... Read More
-
Lumos Pharma Inc (LUMO) - Financial and Strategic SWOT Analysis Review
Lumos Pharma Inc (LUMO) - Financial and Strategic SWOT Analysis Review Lumos Pharma Inc (LUMO) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a cle ... Read More
-
Pharmaniaga Berhad (PHARMA) - Financial and Strategic SWOT Analysis Review
Pharmaniaga Berhad (PHARMA) - Financial and Strategic SWOT Analysis Review Pharmaniaga Berhad (PHARMA) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to y ... Read More
-
Transmucosal Drug Delivery Pipeline Report including Stages of Development, Segments, Region and Countries, Regulatory Path and Key Companies, 2024 Update
Transmucosal Drug Delivery Pipeline Report including Stages of Development, Segments, Region and Countries, Regulatory Path and Key Companies, 2024 Update Summary GlobalData's Medical Devices sector report, “Transmucosal Drug Delivery Pipeline Report including Stages of Development, Segments, Region ... Read More
-
Blood Pressure Monitors Pipeline Report including Stages of Development, Segments, Region and Countries, Regulatory Path and Key Companies, 2024 Update
Blood Pressure Monitors Pipeline Report including Stages of Development, Segments, Region and Countries, Regulatory Path and Key Companies, 2024 Update Summary GlobalData's Medical Devices sector report, “Blood Pressure Monitors Pipeline Report including Stages of Development, Segments, Region and C ... Read More
-
Peripheral Nerve Stimulators (PNS) Pipeline Report including Stages of Development, Segments, Region and Countries, Regulatory Path and Key Companies, 2024 Update
Peripheral Nerve Stimulators (PNS) Pipeline Report including Stages of Development, Segments, Region and Countries, Regulatory Path and Key Companies, 2024 Update Summary GlobalData's Medical Devices sector report, “Peripheral Nerve Stimulators (PNS) Pipeline Report including Stages of Development, ... Read More
-
Aspen Pharmacare Holdings Ltd (APN) - Financial and Strategic SWOT Analysis Review
Aspen Pharmacare Holdings Ltd (APN) - Financial and Strategic SWOT Analysis Review Aspen Pharmacare Holdings Ltd (APN) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalDa ... Read More
-
Synairgen Plc (SNG) - Financial and Strategic SWOT Analysis Review
Synairgen Plc (SNG) - Financial and Strategic SWOT Analysis Review Synairgen Plc (SNG) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and a ... Read More
-
Inborn Gene or Chromosome Alterations Pipeline Report including Stages of Development, Segments, Region and Countries, Regulatory Path and Key Companies, 2024 Update
Inborn Gene or Chromosome Alterations Pipeline Report including Stages of Development, Segments, Region and Countries, Regulatory Path and Key Companies, 2024 Update Summary GlobalData's Medical Devices sector report, “Inborn Gene or Chromosome Alterations Pipeline Report including Stages of Devel ... Read More
-
Cataract Surgery Devices Pipeline Report including Stages of Development, Segments, Region and Countries, Regulatory Path and Key Companies, 2024 Update
Cataract Surgery Devices Pipeline Report including Stages of Development, Segments, Region and Countries, Regulatory Path and Key Companies, 2024 Update Summary GlobalData's Medical Devices sector report, “Cataract Surgery Devices Pipeline Report including Stages of Development, Segments, Region a ... Read More
Research Assistance
